|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-11-2
|
|
pubmed:abstractText |
Anti-tumor-necrosis-factor-alpha (anti-TNF-?) medications are effective in inflammatory bowel disease (IBD), but have an increased risk of tuberculosis (TB) and serious infections. The aim of this study was to examine the Australian/New Zealand experience of serious infections and TB in IBD patients receiving anti-TNF-? therapy from 1999-2009.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1440-1746
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1732-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21039834-Adolescent,
pubmed-meshheading:21039834-Adult,
pubmed-meshheading:21039834-Aged,
pubmed-meshheading:21039834-Aged, 80 and over,
pubmed-meshheading:21039834-Analysis of Variance,
pubmed-meshheading:21039834-Anti-Inflammatory Agents,
pubmed-meshheading:21039834-Antibodies, Monoclonal,
pubmed-meshheading:21039834-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:21039834-Australia,
pubmed-meshheading:21039834-Bacterial Infections,
pubmed-meshheading:21039834-Chi-Square Distribution,
pubmed-meshheading:21039834-Child,
pubmed-meshheading:21039834-Child, Preschool,
pubmed-meshheading:21039834-Colitis, Ulcerative,
pubmed-meshheading:21039834-Crohn Disease,
pubmed-meshheading:21039834-Female,
pubmed-meshheading:21039834-Herpes Zoster,
pubmed-meshheading:21039834-Humans,
pubmed-meshheading:21039834-Immunocompromised Host,
pubmed-meshheading:21039834-Infant,
pubmed-meshheading:21039834-Male,
pubmed-meshheading:21039834-Middle Aged,
pubmed-meshheading:21039834-New Zealand,
pubmed-meshheading:21039834-Opportunistic Infections,
pubmed-meshheading:21039834-Tuberculosis,
pubmed-meshheading:21039834-Tumor Necrosis Factor-alpha,
pubmed-meshheading:21039834-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
|
|
pubmed:affiliation |
The Centre for Inflammatory Bowel Diseases, Fremantle Hospital, University of Western Australia, Fremantle, Western Australia, Australia. ian.lawrance@uwa.edu.au
|
|
pubmed:publicationType |
Journal Article
|
